Clinical Trial Update: Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is registered to evaluate Ganagliflozin for slowing the progression of kidney disease in patients with type 2 diabetes mellitus and chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ganagliflozin (ganagliflozin)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus), CKD - Chronic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING